Similar articles for PMID: 26338896

Year	Number of Results
1997	1
1999	1
2000	6
2001	6
2002	6
2003	8
2004	9
2005	9
2006	11
2007	11
2008	7
2009	15
2010	9
2011	15
2012	19
2013	17
2014	25
2015	22
2016	26
2017	36
2018	31
2019	43
2020	42
2021	35
2022	36
2023	21
2024	1

1

Inverse Agonist of Estrogen-Related Receptor γ Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer Cells.

Singh TD, Jeong SY, Lee SW, Ha JH, Lee IK, Kim SH, Kim J, Cho SJ, Ahn BC, Lee J, Jeon YH. Singh TD, et al. J Nucl Med. 2015 Nov;56(11):1690-6. doi: 10.2967/jnumed.115.160366. Epub 2015 Sep 3. J Nucl Med. 2015. PMID: 26338896 Free article.

2

An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na⁺/I^- Symporter Function in Radioiodine-Refractory Papillary Thyroid Cancer Cells.

Singh TD, Lee JE, Son KH, Lee BR, Kim SK, Gulwani D, Sarangthem V, Jeon YH. Singh TD, et al. Cells. 2023 Feb 1;12(3):470. doi: 10.3390/cells12030470. Cells. 2023. PMID: 36766812 Free PMC article.

3

Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer.

Kim J, Song J, Ji HD, Yoo EK, Lee JE, Lee SB, Oh JM, Lee S, Hwang JS, Yoon H, Kim DS, Lee SJ, Jeong M, Lee S, Kim KH, Choi HS, Lee SW, Park KG, Lee IK, Kim SH, Hwang H, Jeon YH, Chin J, Cho SJ. Kim J, et al. J Med Chem. 2019 Feb 28;62(4):1837-1858. doi: 10.1021/acs.jmedchem.8b01296. Epub 2019 Feb 4. J Med Chem. 2019. PMID: 30657313

4

A Novel Orally Active Inverse Agonist of Estrogen-related Receptor Gamma (ERRγ), DN200434, A Booster of NIS in Anaplastic Thyroid Cancer.

Singh TD, Song J, Kim J, Chin J, Ji HD, Lee JE, Lee SB, Yoon H, Yu JH, Kim SK, Yoon GS, Hwang H, Lee HW, Oh JM, Lee SW, Lee J, Choi HS, Na SY, Choi WI, Park YJ, Song YS, Kim YA, Lee IK, Cho SJ, Jeon YH. Singh TD, et al. Clin Cancer Res. 2019 Aug 15;25(16):5069-5081. doi: 10.1158/1078-0432.CCR-18-3007. Epub 2019 Apr 22. Clin Cancer Res. 2019. PMID: 31010838

5

Mitogen-activated protein kinase signaling enhances sodium iodide symporter function and efficacy of radioiodide therapy in nonthyroidal cancer cells.

Jung KH, Paik JY, Ko BH, Lee KH. Jung KH, et al. J Nucl Med. 2008 Dec;49(12):1966-72. doi: 10.2967/jnumed.108.055764. Epub 2008 Nov 7. J Nucl Med. 2008. PMID: 18997042 Free article.

6

A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer.

Oh JM, Baek SH, Gangadaran P, Hong CM, Rajendran RL, Lee HW, Zhu L, Gopal A, Kalimuthu S, Jeong SY, Lee SW, Lee J, Ahn BC. Oh JM, et al. Thyroid. 2020 Apr;30(4):501-518. doi: 10.1089/thy.2018.0626. Epub 2020 Feb 14. Thyroid. 2020. PMID: 31928162

7

Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.

Schmohl KA, Dolp P, Schug C, Knoop K, Klutz K, Schwenk N, Bartenstein P, Nelson PJ, Ogris M, Wagner E, Spitzweg C. Schmohl KA, et al. Thyroid. 2017 Dec;27(12):1534-1543. doi: 10.1089/thy.2017.0290. Epub 2017 Nov 10. Thyroid. 2017. PMID: 29032724

8

MEK Inhibition Induces Therapeutic Iodine Uptake in a Murine Model of Anaplastic Thyroid Cancer.

ElMokh O, Taelman V, Radojewski P, Roelli MA, Stoss A, Dumont RA, Dettmer MS, Phillips WA, Walter MA, Charles RP. ElMokh O, et al. J Nucl Med. 2019 Jul;60(7):917-923. doi: 10.2967/jnumed.118.216721. Epub 2018 Nov 21. J Nucl Med. 2019. PMID: 30464041 Free article.

9

Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.

Pugliese M, Fortunati N, Germano A, Asioli S, Marano F, Palestini N, Frairia R, Boccuzzi G, Catalano MG. Pugliese M, et al. Thyroid. 2013 Jul;23(7):838-46. doi: 10.1089/thy.2012.0359. Thyroid. 2013. PMID: 23531031 Free article.

10

Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.

Reddi HV, Madde P, McDonough SJ, Trujillo MA, Morris JC 3rd, Myers RM, Peng KW, Russell SJ, McIver B, Eberhardt NL. Reddi HV, et al. Cancer Gene Ther. 2012 Sep;19(9):659-65. doi: 10.1038/cgt.2012.47. Epub 2012 Jul 13. Cancer Gene Ther. 2012. PMID: 22790962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

420 results

Results by year